On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking revenue and profitability. Read more here.

To expand, Aurora has been focusing on selling medical marijuana products internationally, where it can sell at higher prices and produce better margins for the business. It was the international ...

Hedge funds and other institutional investors own 47.63% of the company’s stock. Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis ...

Get Our Latest Research Report on Aurora Cannabis Aurora Cannabis Trading Down 3.7 % TSE:ACB opened at C$8.63 on Friday. The stock’s 50 day moving average price is C$6.08 and its 200 day moving ...

In combination with improved efficiency in the company's manufacturing operations and recent cost reduction initiatives, Aurora's medical cannabis gross margin increased by 600 basis points ...

EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia Aurora Logo (CNW Group/Aurora ...

The term of the agreement is for three years with an option to extend and an estimated value of $27 million. EDMONTON — Aurora Cannabis signs a supply agreement with SNDL, a Canadian licensed ...